Drug Discovery and Development 2023 Predictions

Drug Discovery and Development highlighted key drug discovery and development predictions for 2023. Antheia was highlighted for its take on the synbio industry’s renewed focus on “how, as a global community…
Leveraging Fermentation to Produce Complex APIs

In this Contract Pharma Q&A, we sat down with Kristin Brooks to discuss how our company uses fermentation to produce complex APIs for essential medicines. Fermentation and synthetic biology have evolved dramatically…
Demystifying Synthetic Biology Part V: The Product is Key in Downstream Processing

Upstream bioprocessing – better known in biomanufacturing as fermentation – is directly followed by downstream bioprocessing (DSP). Just as fermentation is all about maximizing the production of a target compound, DSP focuses
Demystifying Synthetic Biology IV: Fermentation Bioprocess Development

Fermentation is one of humanity’s oldest and most pivotal technological developments. Through fermentation, societies began adapting their diets nearly ten millennia ago, to include new and innovative foods such as alcohol and leavened bread…
Demystifying Synthetic Biology III: The 21st Century Technologies Advancing Synthetic Biology

Synthetic biology is often touted as a software-driven and automation-empowered approach to biological research. Buzzwords like artificial intelligence and robotics are commonly used alongside the phrase synthetic biology, leading…
Demystifying Synthetic Biology II: Molecular Biology Advancements Enabling Synthetic Biology

Synthetic biology seems like a brand-new, precision scientific field – just bursting with potential – but is it really all that new? Biology is often seen as the unpredictable cousin of the math-based sciences chemistry and physics…
Syn Bio Companies Put the Earth into Focus

While some synthetic biology companies are using biology to improve our food, clothes, and medicine, others are turning their attention to helping the Earth.
Demystifying Synthetic Biology: Building with the power of biology

Technology today is defined by superlatives: we have the fastest cars, the best medicine, and the most advanced communication tools ever known. Yet despite humanity’s technological progress…
Seven Biopharma Trends to Watch in 2022

Synthetic biology attracted $8.9 billion in venture funding during the first half of 2021, according to synbio stakeholder group SynBioBeta, and launched two successful initial public offerings: Zymergen’s $529.6 million traditional IPO and Ginkgo Bioworks…
Can Synthetic Biology Save Us? This Scientist Thinks So.

Drew Endy is squarely focused on the potential of redesigning organisms for useful purposes. He also acknowledges significant challenges…